Medical device tax helps push Spectranetics further into the red in Q1

April 24, 2013 by Arezu Sarvestani

Spectranetics blames the newly implemented medical device tax as partly responsible for the company's shift from black ink for 4 straight quarters to a net loss in Q1 2013.

Spectranetics logo

Colorado-based medical device maker Spectranetics (NSDQ:SPNC) broke out the red ink in 2013, blaming the swing partly on the newly implemented medtech excise tax, which requires that companies pay a 2.3% levy on all U.S. sales of applicable medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.